Pharma Strategy Blog

Commentary on Pharma & Biotech Oncology / Hematology New Product Development

I was checking out a paper today in Molecular Cancer Therapeutics and was rather surprised, nay astounded, to see a prominent link to social bookmarking (see graphic).

Wow!

Guess what the options were on clicking the link? 

  • Delicious
  • Digg
  • Connotea
  • CiteULike
  • Complore

Complore?  What the hell is that?  Oh, a site for Indians studying for their MBA entrance exams for qual and quant analysis, it seems.  Eeek, what is that doing in a cancer journal?

No StumbleUpon, Mendeley, Zotero, Diigo? 

It seems a bit of an arbitrary list but hey, we technology friendly scientists should be pleased to see any bookmarking I suppose, but still. The only one I personally use in their list is Delicious but increasingly prefer Zotero and Diigo for social bookmarking. 

Ah well, I look forward to seeing a Share This widget, then you can choose your sharing options more freely.

Are these appearing in mainstream journals in other therapy areas?

If so, that's a good reason as any to have some fireworks on July 4th 😉

Posted via email from sallychurch’s posterous

One Response to “Social Bookmarking finally comes to serious cancer journals?”

  1. Adam

    I chanced upon to view your blog and found it very interesting. Great … Keep it up!

Comments are closed.

error:
error: Content is protected !!